CWM
PFE icon

Chesapeake Wealth Management’s Pfizer PFE Stock Holding History

Chesapeake Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,031
Closed -$204K – 163
2024
Q3 		$204K Buy
+7,031
New +$205K 0.07% 155
2024
Q2 		– Sell
-8,116
Closed -$225K – 158
2024
Q1 		$225K Sell
8,116
-378
-4% -$10.5K 0.08% 146
2023
Q4 		$245K Sell
8,494
-2,746
-24% -$83K 0.09% 136
2023
Q3 		$373K Sell
11,240
-958
-8% -$33.9K 0.16% 112
2023
Q2 		$447K Sell
12,198
-413
-3% -$16.1K 0.18% 104
2023
Q1 		$515K Sell
12,611
-275
-2% -$11.9K 0.21% 99
2022
Q4 		$660K Sell
12,886
-50
-0.4% -$2.4K 0.29% 91
2022
Q3 		$566K Sell
12,936
-175
-1% -$8.5K 0.26% 91
2022
Q2 		$687K Sell
13,111
-413
-3% -$21K 0.29% 86
2022
Q1 		$700K Sell
13,524
-240
-2% -$12.5K 0.25% 98
2021
Q4 		$813K Sell
13,764
-106
-0.8% -$5.25K 0.27% 91
2021
Q3 		$597K Sell
13,870
-955
-6% -$42.3K 0.21% 106
2021
Q2 		$580K Sell
14,825
-877
-6% -$34.1K 0.19% 116
2021
Q1 		$569K Sell
15,702
-1,066
-6% -$37.8K 0.19% 119
2020
Q4 		$617K Sell
16,768
-1,743
-9% -$63.9K 0.21% 111
2020
Q3 		$645K Sell
18,511
-414
-2% -$14.5K 0.24% 99
2020
Q2 		$587K Buy
18,925
+623
+3% +$21.2K 0.23% 102
2020
Q1 		$567K Sell
18,302
-1,794
-9% -$61.1K 0.26% 97
2019
Q4 		$747K Sell
20,096
-1,280
-6% -$45.6K 0.29% 93
2019
Q3 		$729K Buy
21,376
+394
+2% +$14.3K 0.3% 96
2019
Q2 		$862K Sell
20,982
-110
-0.5% -$4.37K 0.36% 87
2019
Q1 		$850K Buy
21,092
+169
+0.8% +$6.77K 0.37% 82
2018
Q4 		$866K Sell
20,923
-32
-0.2% -$1.33K 0.43% 65
2018
Q3 		$876K Sell
20,955
-685
-3% -$26.4K 0.39% 69
2018
Q2 		$745K Buy
21,640
+480
+2% +$16.4K 0.34% 80
2018
Q1 		$712K Buy
+21,160
New +$727K 0.33% 84

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chesapeake Wealth Management's PFE Position: Q4 2024 in Review

Chesapeake Wealth Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,031 shares — an estimated $204K sold.

Chesapeake Wealth Management first reported a position in PFE in Q1 2018 and held it in 26 quarters. The position peaked at $876K in Q3 2018. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Chesapeake Wealth Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Chesapeake Wealth Management sold 7,031 Pfizer shares in Q4 2024, an estimated $204K.
  • Chesapeake Wealth Management first reported a position in Pfizer in Q1 2018 and held it in 26 quarters.
  • Chesapeake Wealth Management's Pfizer position peaked at $876K in Q3 2018.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Chesapeake Wealth Management's 13F filing for Q4 2024, filed 16 Jan 2025.